Skip to content

Breast Cancer Health Center

Font Size

Breast Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Harms of Screening Mammography

Mammography screening may be effective in reducing breast cancer mortality in certain populations, but it can pose harm to women who participate. The limitations are best described as false-positives (related to the specificity of the test), overdiagnosis (true-positives that will not become clinically significant), false-negatives (related to the sensitivity of the test), discomfort associated with the test, radiation risk and anxiety.

Table 3 provides an overview of the estimated benefits and harms of screening mammography for 10,000 women who undergo annual screening mammography over a 10-year period.[1]

Table 3. Estimated Benefits and Harms of Mammography Screening for 10,000 Women Who Undergo Annual Screening Mammography Over a 10-Year Perioda

Age, yNo. of Breast Cancer Deaths Averted With Mammography Screening Over Next 15 ybNo. (95% CI) With ≥1 False-Positive Result During the 10 ycNo. (95% CI) With ≥1 False Positive Resulting in a Biopsy During the 10 ycNo. of Breast Cancers or DCIS Diagnosed During the 10 y That Would Never Become Clinically Important (Overdiagnosis)d
No. = number; CI = confidence interval; DCIS = ductal carcinomain situ.
a Adapted from Pace and Keating.[1]
b Number of deaths averted are from Welch and Passow.[2]The lower bound represents breast cancer mortality reduction if the breast cancer mortality relative risk were 0.95 (based on minimal benefit from the Canadian trials[3,4]), and the upper bound represents the breast cancer mortality reduction if the relative risk were 0.64 (based on the Swedish 2-County Trial[5]).
c False-positive and biopsy estimates and 95% confidence intervals are 10-year cumulative risks reported in Hubbard et al.[6]and Braithwaite et al.[7]
d Overdiagnosed cases are calculated by Welch and Passow.[2]The lower bound represents overdiagnosis based on results from the Malmö trial,[8]whereas the upper bound represents the estimate from Bleyer and Welch.[9]
e The lower-bound estimate for overdiagnosis reported by Welch and Passow[2]came from the Malmö study.[8]The study did not enroll women younger than 50 years.
401–166,130 (5,940–6,310)700 (610–780)?–104e
503–326,130 (5,800–6,470)940 (740–1,150)30–137
605–494,970 (4,780–5,150)980 (840–1,130)64–194
    1|2|3|4|5|6
    Next Article:

    Today on WebMD

    Breast Cancer Overview
    From self-exams and biopsies to reconstruction, we’ve got you covered.
    Dealing with breast cancer
    Get answers to your questions.
     
    woman having mammogram
    Experts don’t agree on all fronts, but you can be your own advocate.
    woman undergoing breast cancer test
    Many women worry. But the truth? Most abnormalities aren’t breast cancer.
     
    Breast Cancer Treatments Improving
    VIDEO
    Resolved To Quit Smoking
    SLIDESHOW
     
    Woman getting mammogram
    Article
    Screening Tests for Women
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    serious woman
    Article
     
    what is your cancer risk
    HEALTH CHECK
    10 Ways to Revitalize Slideshow
    SLIDESHOW